NASDAQ:KRMD
KORU Medical Systems, Inc.
KORU Medical Systems, Inc.'s revenue grew 22.2% in fiscal 2025 to $41.1M while operating margin rose to −7.2%. Free cash flow was −$470,112, −1.1% of revenue, and the diluted share count rose 0.8%.Summary generated from KORU Medical Systems, Inc.'s SEC filings. Latest annual report filed Mar 12, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$41.1M
Revenue growth+22.2%
Revenue, 5-yr CAGR+11.2%
Gross margin62.3%
Operating margin−7.2%
Net margin−6.4%
ROICn/a
Return on equity−15.6%
Debt / equityn/a
Free cash flow−$470,112
FCF margin−1.1%
Share count change+0.8%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 23 | 28 | 29 | 34 | 41 |
| Operating income | −7 | −11 | −10 | −6 | −3 |
| Net income | −5 | −9 | −14 | −6 | −3 |
| Free cash flow | −5 | −8 | −6 | −2 | −0 |
Recent filings
- 4Insider transaction report
Oct 1, 2026 - 4Insider transaction report
Oct 1, 2026 - 8-KAmendment to articles or bylaws
Aug 14, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 5, 2026 - 8-KEntry into a material agreement
Jun 30, 2026 - 8-KResults of a shareholder vote
May 21, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 6, 2026